PHVS vs REGN: Which Stock is Better?
Side-by-side comparison of Pharvaris BV and Regeneron Pharmaceuticals Inc in 2026
PHVS
Pharvaris BV
—
REGN
Regeneron Pharmaceuticals Inc
$664.23
Key Metrics Comparison
| Metric | PHVS | REGN | Winner |
|---|---|---|---|
| Market Cap | $2.21B | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHVS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHVS or REGN a better investment?
Comparing PHVS and REGN: Pharvaris BV has a market cap of $2.21B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHVS and REGN?
PHVS (Pharvaris BV) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHVS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHVS or REGN?
Both PHVS and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHVS or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHVS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $2.21B for PHVS.
Should I buy PHVS or REGN in 2026?
Both PHVS and REGN have investment merit. PHVS trades at $N/A while REGN trades at $664.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHVS and REGN stock?
Key differences: Market Cap ($2.21B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHVS or REGN in 2026?
The choice between PHVS and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHVS and REGN?
PHVS (Pharvaris BV) has a market cap of $2.21B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.